BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 2716749)

  • 21. [Recombinant human erythropoietin in the therapy of anemia in hemodialyzed patients].
    Kakuk G; Kárpáti I; Mátyus J
    Orv Hetil; 1990 Oct; 131(43):2365-6, 2369-71. PubMed ID: 2234936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human recombinant erythropoietin in the treatment of anaemia in chronic haemodialysis patients.
    Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartûsková J; Válek A
    Czech Med; 1990; 13(2-3):98-106. PubMed ID: 2245762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleotide and glutathione status in erythrocytes of children undergoing chronic hemodialysis under erythropoietin treatment.
    Sachs G; Siems W; Grune T; Schmidt G; Gerber G; Zoellner K
    Biomed Biochim Acta; 1990; 49(2-3):S123-4. PubMed ID: 2386496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epoetin omega for treatment of anemia in maintenance hemodialysis patients.
    Sikole A; Spasovski G; Zafirov D; Polenakovic M
    Clin Nephrol; 2002 Mar; 57(3):237-45. PubMed ID: 11924756
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effect of recombinant human erythropoietin--rHu-EPO on the metabolism of children treated by long-term hemodialysis].
    Pietrzyk JA; Smolnik T; Szymowska M; Dyras P; Lenik J
    Przegl Lek; 1992; 49(1-2):55-60. PubMed ID: 1455008
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcome of renal transplantation in patients treated with erythropoietin.
    Linde T; Wahlberg J; Wikström B; Danielson BG
    Clin Nephrol; 1992 May; 37(5):260-3. PubMed ID: 1606776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of recombinant human erythropoietin on sodium balance in nondialysed children with chronic renal failure.
    Kavukçu S; Saatci U; Ciliv G; Söylemezoğlu O; Bakkaloğlu A; Besbas N; Ozen S
    Int Urol Nephrol; 1993; 25(6):611-5. PubMed ID: 8175282
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of recombinant human erythropoietin therapy on ambulatory blood pressure in normotensive and in untreated borderline hypertensive hemodialysis patients.
    Lebel M; Kingma I; Grose JH; Langlois S
    Am J Hypertens; 1995 Jun; 8(6):545-51. PubMed ID: 7662237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of recombinant erythropoietin on secondary anemia in patients in the terminal phase of renal insufficiency on hemodialysis].
    Gasparović V; Puretić Z; Vrhovac B; Gjurasin M; Puljević D
    Acta Med Iugosl; 1990; 44(2):129-35. PubMed ID: 2353593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP; Abels RI; McNeill MV; Sullivan DJ
    Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant human erythropoietin therapy in haemodialysis patients--dose determination and clinical experience.
    Bommer J; Alexiou C; Müller-Bühl U; Eifert J; Ritz E
    Nephrol Dial Transplant; 1987; 2(4):238-42. PubMed ID: 3118264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of anemia in patients on a regular dialysis program using human recombinant erythropoietin].
    Sulková S; Kvasnicka J; Kasl M; Kozlová J; Podrouzek P; Bartůnková J; Válek A
    Cas Lek Cesk; 1989 Sep; 128(40):1257-60. PubMed ID: 2582471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo effects of recombinant human erythropoietin on bone marrow hematopoiesis in patients with chronic renal failure.
    Biljanović-Paunović L; Djukanović L; Lezaić V; Stojanović N; Marisavljević D; Pavlović-Kentera V
    Eur J Med Res; 1998 Dec; 3(12):564-70. PubMed ID: 9889177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Guidelines for recombinant human erythropoietin therapy.
    Eschbach JW; Adamson JW
    Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):2-8. PubMed ID: 2667349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversing the anemia of renal failure.
    Hatch FE
    Hosp Pract (Off Ed); 1990 Feb; 25(2A):25-34. PubMed ID: 2105980
    [No Abstract]   [Full Text] [Related]  

  • 36. Practical considerations of recombinant human erythropoietin therapy.
    Paganini EP; Latham D; Abdulhadi M
    Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):19-25. PubMed ID: 2667348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pediatric uses of recombinant human erythropoietin: the outlook in 1991.
    Alexander SR
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):42-53. PubMed ID: 1928079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 2004 Japanese Society for Dialysis Therapy guidelines for renal anemia in chronic hemodialysis patients.
    Gejyo F; Saito A; Akizawa T; Akiba T; Sakai T; Suzuki M; Nishi S; Tsubakihara Y; Hirakata H; Bessho M;
    Ther Apher Dial; 2004 Dec; 8(6):443-59. PubMed ID: 15663544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Erythropoietin--the first hematologic hormone in clinical use].
    Rhyner K
    Schweiz Med Wochenschr; 1988 Mar; 118(11):375-80. PubMed ID: 3287601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Anemia in chronic renal insufficiency--case report].
    Popović M
    Med Pregl; 1999; 52(6-8):279-81. PubMed ID: 10518388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.